SEOM clinical guidelines for anaemia treatment in cancer patients (2020)
Por:
Alvarez Y, Bataller R, Altozano J, Martinez S, Alvarez A, Cordellat A, Vazquez E, Jaime J, Escobar I, Zambrano C
Publicada:
1 may 2021
Ahead of Print:
1 mar 2021
Resumen:
Anaemia is defined by the presence of haemoglobin (Hb) levels < 13 g/dL in men and 12 g/dL in women. Up to 39% of cancer patients present it at the time of diagnosis and up to 40% have iron deficiency. Anaemia causes fatigue, functional deterioration and a reduction in the quality of life; it has also been associated with a poorer response to anti-tumour treatment and lower survival. Basic diagnostic tests for anaemia are simple and should be a routine part of clinical practice. These guidelines review the available evidence on the use of different therapies for treating anaemia: erythropoiesis-stimulating agents, iron supplements, and transfusion of blood products.
Filiaciones:
Alvarez Y:
Hosp Gen Univ Gregorio Maranon, Dept Med Oncol, Madrid, Spain
Bataller R:
Consorcio Hosp Prov Castellon, Dept Med Oncol, Castellon De La Plana, Spain
Altozano J:
Hosp Virgen Lirios, Dept Med Oncol, Alcoy, Spain
Martinez S:
Hosp Univ Virgen Arrixaca, Dept Med Oncol, Murcia, Spain
Alvarez A:
Hosp Univ Puerta Mar, Dept Med Oncol, Cadiz, Cadiz, Spain
Cordellat A:
Consorcio Hosp Gen Univ, Dept Med Oncol, Valencia, Spain
Vazquez E:
Hospitalario Clin Univ Santiago, Dept Med Oncol, La Coruna, Spain
Jaime J:
Clin Univ Navarra, Dept Med Oncol, Madrid, Spain
Escobar I:
Hosp Gen Univ Virgen Nieves, Granada, Spain
Zambrano C:
Hosp Univ Jerez Frontera, Dept Med Oncol, Cadiz, Cadiz, Spain
hybrid, Green Published
|